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Background and purpose   Although decreasing with the devel-
opment of effective pharmacological regimes, joint surgery has 
improved the function and quality of life of patients with rheu-
matoid arthritis (RA). Few studies have assessed patient-reported 
outcomes after RA surgery to the lower extremities. Here we 
report patient-relevant outcome after RA-related surgery based 
on the first data from the Swedish National Register of Rheuma 
Surgery (RAKIR). 
Patients and methods   258 RA patients (212 women) who had 
joint surgery performed at the Department of Orthopaedics, 
Spenshult Hospital between September 2007 and June 2009 were 
included. Mean age at surgery was 64 (20–86) years. The patients 
completed the SF-36 and HAQ questionnaires preoperatively and 
6 months postoperatively, and 165 patients completed them after 
12 months. 
Results   Improvement was seen as early as at 6 months. At 12 
months, 165 patients (141 women)—including hip (n = 15), knee 
(n = 27), foot (n = 102), and ankle (n = 21) patients—reported 
statistically significant improvements from preoperatively to 12 
months postoperatively in HAQ (mean change: –0.11) and SF-36 
subscales physical function (11), role physical (12), bodily pain 
(13), social functioning (6.4), and role emotional (9.4). Hip and 
knee patients reported the greatest improvements. 
Interpretation   Orthopedic RA-related surgery of the lower 
extremities has a strong effect on pain and physical function. 
Improvement is evident as early as 6 months postoperatively and 
remains after 12 months.

Rheumatoid arthritis (RA) can have a major effect on health-
related quality of life and can lead to reduction in physical 
function and in mental health (Doyle 2001, Kosinski et al. 
2002, Boonen and Severens 2011). Orthopedic surgery has 
improved the function and quality of life of patients with RA. 
A decreasing rate of RA-related orthopedic surgery in the 
Nordic countries has been reported (Eskelinen et al. 2006, 
Weiss et al. 2006, Kapetanovic et al. 2008, Havelin et al. 2009, 
Robertsson et al. 2010) and has been explained by the devel-
opment of more effective pharmacological regimes (da Silva 
et al. 2003, Kapetanovic et al. 2008, Uhlig et al. 2008, Weiss et 
al. 2008, Söderlin et al. 2010). However, if medical treatment 
fails, surgical intervention is needed. Patient-related outcome 
measures are frequently used to quantify the effectiveness 
of treatment and the long-term effect of RA on the patient’s 
functioning and well-being (Kosinski et al. 2000, Linde et al. 
2008, Uhlig et al. 2008). Some recent studies have evaluated 
the effect of orthopedic interventions in other patient groups 
(Nilsdotter et al. 2009, Jansson and Granath 2011). Few stud-
ies have assessed patient-relevant outcomes after orthopedic 
surgery in patients with RA. 
The Swedish National Register of Rheuma Surgery (RAKIR) 
was established in 2007 and has been used at Spenshult Hos-
pital for Rheumatic Diseases. The main aim of RAKIR is to 
measure how surgical procedures affect pain, function, activ-
ity, and quality of life in RA patients, in order to improve the 
results. Data on patient-reported pain, function, and health-
related quality of life of patients undergoing surgery have 
been registered since September 2007, together with data on 
complications and revision surgery. The objective of this study 
was to examine the effect of RA-related surgical interventions 
in the lower extremities, as measured by the patient-adminis-
tered questionnaires HAQ and SF-36. This analysis is based 
on the first data from RAKIR. 
Methods
Patients
Between September 2007 and June 2009, 516 operations in the 
lower extremities were performed in 439 patients at Spenshult 
Hospital for Rheumatic Diseases (Figure 1). Patients undergo-180  Acta Orthopaedica 2012; 83 (2): 179–184
ing surgery were asked to complete the patient-administered 
questionnaires SF-36 and HAQ preoperatively at the ward. 
The same questionnaires were sent to the patients by mail 6 
months and 12 months postoperatively without any reminders. 
The procedures were all RA-related joint surgery (Table 1). 
Operation codes were divided into 4 groups according to the 
anatomical region: hip, knee, foot, and ankle. Preoperative data 
were available for 261 patients. 28 patients underwent surgery 
twice or more, and completed the preoperative questionnaires 
at least once during the study period, but only data referring to 
the first intervention were analyzed. 3 patients were excluded 
either due to surgery of the upper extremity in the same ses-
sion (n = 1) or due to operations unrelated to RA (n = 2). Data 
for the remaining 258 patients (212 women) were analyzed: 
26 hip patients, 39 knee patients, 162 foot patients, and 31 
ankle patients. Mean age at surgery was 64 (20–86) years. 98 
patients had had one or more previous intervention performed, 
including hand/wrist (n = 49), elbow (n = 16), shoulder (n = 
7), back or neck (n = 9), hip (n = 21), knee (n = 30), and 
foot (n = 60) patients. The individual change in SF-36 and 
HAQ scores was calculated as the difference between scores 
preoperatively and at 12 months postoperatively. Peroperative 
complications were reported in 7 patients (hip, n = 2; foot, n = 
2; ankle, n = 2; knee, n = 1). Postoperative complications were 
reported in 3 patients. 
Questionnaires
The Medical Outcome Study Short Form-36 (SF-36) (Ware 
and Sherbourne 1992) includes one multi-item scale that 
assesses 8 dimensions of health: physical functioning (PF), 
social functioning (SF), role limitations because of physical 
health problems (RP), bodily pain (BP), general mental health 
(psychological distress and well-being; MH), limitations in 
usual role activities because of emotional problems (RE), vital-
ity (energy and fatigue; VT), and general health perceptions 
(GH). Each subscale is scored from 0 to 100, with 0 indicating 
extreme problems and 100 indicating no problems. The SF-36 
is a widely used generic measure of health status and has been 
validated for Swedish conditions (Sullivan et al. 1993). 
The Stanford Health Assessment Questionnaire (HAQ) dis-
ability index (Fries et al. 1980) is a disease-specific question-
naire containing 20 items and assesses the degree of difficulty 
in performing activities of daily living during the previous 
week. The following response categories are available for each 
question: without any difficulty (score 0), with some difficulty 
(score 1), with much difficulty (score 2), or unable to do (score 
3). The activities are grouped into 8 dimensions: dressing and 
grooming, rising, eating, walking, hygiene, reach, grip, and 
other activities. The HAQ is widely used internationally in 
patients with RA—in clinical practice as well as in research. 
It has been translated and validated for Swedish conditions 
(Ekdahl et al. 1988).
Statistics 
For comparison of preoperative and follow-up questionnaire 
data, Friedman’s test (comparing baseline data, 6-month data, 
and 12-month data) and Wilcoxon’s signed rank test (com-
paring pairwise data between 2 different examinations, e.g., 
baseline data and 12-month data) were used. To quantify mean 
changes in measured outcomes during follow-up, the paired 
t-test was used for computation of 95% confidence intervals 
(CIs). For comparisons between groups, the Mann-Whitney 
test was used. Continuous outcomes are given as mean (SD) 
since this is customary in describing SF-36 data. Values of p < 
0.05 were considered significant. 
Power analysis was performed before the start of the study. 
For a difference of 10 units in the SF-36 subscales and a dif-
ference of 0.3 units in the HAQ, with a power of 80% between 
preoperative and postoperative data (p < 0.05), we calculated 
that 35 patients per group would be required. 
We carried out sensitivity analysis to address the issue 
of missing data (loss to follow-up). The sensitivity of the 
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Table 1. Orthopedic interventions
Intervention  n  (%)
Forefoot arthrodesis  77  (29)
Stainsby  31  (11)
Hindfoot arthrodesis   37  (13)
Ankle arthroplasty  13  (5)
Ankle arthrodesis  17  (6)
THR  26  (9)
TKR  34  (12)
Forefoot osteotomy  18  (7)
Phalang resection    9  (3)
Hindfoot osteotomy    2  (1)
Knee arthroscopy    2  (1)
Others    9  (3)Acta Orthopaedica 2012; 83 (2): 179–184  181
reported statistical results for HAQ and SF-36 data was evalu-
ated by imputing baseline data (for the non-responders). Pre- 
and postoperative data, including the imputed values, were 
then compared using Wilcoxon’s signed rank test. Statistical 
analysis was performed with the SPSS software version 17.0.
Ethics
The ethics regional board of Lund approved the study (no. 
521/2007).
 
Results
At the 12-month follow-up, responses were available from 
165 patients (141 women) with a mean age at surgery of 64 
(27–84) years (Table 2). The distribution of surgery was as 
follows: foot (n = 102), ankle (n = 21), knee (n = 27), and hip 
(n = 15). 93 patients did not complete the 12-month follow-up 
questionnaires. There were no statistically significant differ-
ences between responders and non-responders regarding age, 
preoperative HAQ score, or preoperative SF-36 score. Fried-
man’s test showed a difference in mean ranks for HAQ and 
for SF-36 subscales PF, RP, BP, and SF (Table 3). Patients 
reported statistically significant improvements in scores from 
before surgery to 12 months postoperatively in HAQ and in 
SF-36 subscales PF, RP, BP, SF, and RE. Statistically signifi-
cant improvements were evident at 6 months (compared to 
preoperatively) in the same subscales, with the exception of 
RE. VT improved at 6 months but not at 12 months. When 
the subgroups were analyzed separately, foot patients reported 
significant improvement in SF-36 PF, RP, and BP scores at 6 
and 12 months relative to preoperative levels (Table 4). Ankle 
patients had significant improvements in BP and SF compared 
to preoperatively (Table 5). Ankle patients who underwent 
total joint replacement (n = 10) had significant improvement 
in pain, and the improvement in PF was close to significant 
(p = 0.05) while ankle patients who underwent arthrodesis sur-
gery (n = 11) only had significant improvement in SF. Knee 
patients (Table 6) had significant improvements in HAQ and in 
SF-36 PF, RP, BP, VT, SF, and RE at 12 months. Hip patients 
had significant improvements in HAQ and in SF-36 PF, BP, 
VT, SF, and RE at 12 months (Table 7). 
Table 2. Patient characteristics
   Responders  Foot   Ankle  Knee  Hip  Non-responders
n  165  102  21 27 15 93
Women, n (%)  141 (86)  94 (92)  16 (76)  20 (74)  11 (73)  71 (76)
Age in years a   64 (11)  65 (11)  62 (13)  68 (9)  61 (14)  62 (13)
Preoperative HAQ score a  1.1 (0.58)  1.0 (0.56)  1.4 (0.56)  1.2 (0.58)  1.3 (0.60)  1.1 (0.60)
Preoperative SF-36 scores a, b
   PF  39 (23)  44 (23)  28 (17)  35 (22)  28 (22)  41 (23)
   RP  29 (39)  34 (41)  19 (32)  27 (37)  15 (31)  29 (36)
   BP  37 (21)  40 (21)  34 (22)  36 (17)  25 (26)  36 (21)
   GH  52 (21)  51 (21)  51 (19)  51 (20)  59 (22)  52 (22)
   VT  47 (25)  51 (25)  38 (19)  48 (21)  33 (25)  45 (24)
   SF  69 (26)   73 (26)  56 (25)  69 (23)  60 (31)   68 (25)
   RE  58 (45)  64 (44)  51 (44)  42 (49)  60 (44)  62 (42)
   MH  73 (19)  76 (19)  63 (22)  71 (18)  79 (21)  74 (19)
a Values are mean (SD)
b See Methods for a full explanation of the 8 dimensions of the SF-36.
Table 3. HAQ and SF-36 scores before and after surgery (n = 165)
  Baseline  6 months   12 months  Mean change (SD; CI)  p-value   p-value
          (Friedman’s test) 
HAQ score, mean (SD)  1.1 (0.58)  0.99 (0.62)  1.0 (0.62)  –0.11 (0.44; –0.18 to 0.041)  < 0.001  0.006
SF-36 scores, mean (SD)           
   PF  39 (23)  49 (24)  50 (25)  11 (23; 7.3–14)  < 0.001  < 0.001
   RP  29 (39)  44 (41)  41 (42)  12 (41; 5.8–19 )  0.001  < 0.001
   BP  37 (21)  52 (24)  50 (24)  13 (24; 9.5–17)  < 0.001  < 0.001
   GH  52 (21)  52 (23)  50 (21)  –2.2 (19; –5.0 to 0.70)  0.6  0.2
   VT  47 (25)  52 (24)  51 (23)    3.5 (21; 0.24–6.8)  0.1  0.08
   SF  69 (26)   77 (25)  75 (26)    6.4 (24; 2.7–10)  < 0.001   0.001
   RE  58 (45)  67 (42)  67 (42)    9.4 (48; 1.7–17)  0.2  0.01
   MH  73 (19)  77 (20)  74 (20)    0.35 (19; –2.7 to 3.4)  0.2  0.6182  Acta Orthopaedica 2012; 83 (2): 179–184
Table 5. HAQ and SF-36 scores before and after surgery: ankle (n = 21)
  Baseline   6 months  12 months  Mean change (SD; CI)  p-value
HAQ score, mean (SD)  1.4 (0.56)  1.2 (0.53)  1.4 (0.53)    0.00 (0.41; –0.19 to 0.19)  0.8
SF-36 scores, mean (SD)         
   PF  27 (17)  36 (19)  33 (22)    5.1 (21; –4.3 to 15)  0.2
   RP  19 (32)  26 (39)  27 (41)    8.3 (41; –10 to 27)  0.4
   BP  34 (22)  55 (25)  46 (23)  13 (24; 2.0–23)  0.03
   GH  51 (19)  52 (20)  46 (20)  –4.0 (14; –11 to 2.8)  0.2
   VT  38 (19)  43 (27)  46 (19)    8.1 (20; –1.3 to 17)  0.2
   SF  56 (25)  72 (30)  69 (32)  13 (21; 3.7–23)  0.02
   RE  51 (44)  59 (45)  55 (46)    5.0 (56; –21 to 31)  0.7
   MH  63 (22)  70 (23)  71 (18)    7.8 (20; –1.8 to 17)  0.1
Table 6. HAQ and SF-36 scores before and after surgery: knee (n = 27)
  Baseline   6 months  12 months  Mean change (SD; CI)  p-value
HAQ score, mean (SD)  1.2 (0.58)  1.0 (0.62)  1.0 (0.66)  –0.29 (0.29; –0.41 to –0.17)  < 0.001
SF-36 scores, mean (SD)         
   PF  35 (22)  52 (21)  55 (22)  20 (19; 12–27)  < 0.001
   RP  27 (37)  50 (45)  51 (46)  26 (47; 6.9–44)  0.01
   BP  36 (17)  53 (22)  58 (23)  21 (24; 12–31)  < 0.001
   GH  51 (20)  49 (22)  50 (18)  –1.4 (16; –8.0 to 5.1)  0.8
   VT  48 (21)  53 (22)  56 (21)    8.5 (18; 1.4–16)  0.02
   SF  69 (23)  83 (21)  82 (20)  13 (20; 5.7–21)  0.003
   RE  42 (49)  67 (44)  69 (41)  27 (46; 8.3–46)  0.007
   MH  71 (18)  73(20)  76 (20)    5.1 (14; –0.32 to 11)  0.06
Table 4. HAQ and SF-36 scores before and after surgery: foot (n = 102)
  Baseline   6 months  12 months  Mean change (SD; CI)  p-value
HAQ score, mean (SD)  1.0 (0.56)  0.97 (0.63)  0.96 (0.59)  –0.036 (0.41; -0.12-0.048)  0.8
SF-36 scores, mean (SD)          
   PF  44 (23)  50 (24)  51 (24)    7.4 (22; 3.1–12)  < 0.001
   RP  34 (41)  45 (40)  42 (40)    8.4 (40; 0.32–17)  0.03
   BP  40 (21)  49 (23)  48 (22)    8.0 (20; 3.9–12)  < 0.001
   GH  51 (21)  50 (22)  49 (23)  –2.0 (20; –6.0 to 2.0)  0.4
   VT  51 (25)  53 (24)  50 (24)  –1.0 (20; –4.9 to 2.9)  0.5
   SF  73 (26)  76 (24)  75 (26)    1.7 (24; –3.0 to 6.5)  0.4
   RE  64 (44)  66 (42)  67 (42)    3.0 (48; –6.7 to 13)  0.5
   MH  76 (19)  77 (18)  72 (20)  –3.4 (20; –7.4 to 0.59)  0.1
Table 7. HAQ and SF-36 scores before and after surgery: hip (n = 15)
  Baseline   6 months  12 months  Mean change (SD; CI)  p-value
HAQ score, mean (SD)  1.3 (0.60)  0.71 (0.66)  0.87 (0.72)  –0.44 (0.61; –0.78 to –0.11)   0.02
SF-36 scores, mean (SD)         
   PF  28 (22)  58 (25)  54 (27)  25 (28; 9.8–41)  0.008
   RP  15 (31)  50 (41)  35 (45)  20 (39; –1.7 to 42)  0.07
   BP  25 (26)  66 (29)  60 (34)  35 (35; 16–55)   0.006
   GH  59 (22)  68 (25)  57 (21)  –2.1 (16; –11 to 6.9)  0.6
   VT  33 (25)  62 (24)  54 (25)  20 (26; 4.5–35)  0.03
   SF  60 (31)  80 (29)  76 (27)  16 (29; 0.034–32)  0.04
   RE  60 (44)  79 (35)  84 (35)  24 (39; 3.0–46)  0.04
   MH  79 (21)  87 (19)  86 (18)    7.2 (17; –2.4 to 17)  0.2Acta Orthopaedica 2012; 83 (2): 179–184  183
When we imputed baseline data at 12 months, the signifi-
cant p-values originally obtained (for PF, RP, BP, SF, RE, and 
HAQ) were still significant. 
Discussion 
Lower limb function has been shown to deteriorate more than 
upper limb function over a 10-year period in RA patients 
(Ringen et al. 2008). However, few studies have assessed 
patient-relevant outcome after surgery to the lower extremi-
ties. Osnes-Ringen et al. (2009) compared surgery in the 
upper and lower extremities and replacement surgery with 
non-replacement surgery in 255 patients with inflammatory 
arthropathies (two-thirds of whom had RA). As might be 
expected, the largest improvement at 12 months—as mea-
sured by the standard response mean (SRM)—was for pain 
reported from the specific joint that had been operated on. 
SF-36 subscales PF and BP also showed high SRMs, while 
SRMs for GH and HAQ were lower. In a study by March et al. 
(2008) assessing costs and outcomes of total joint replacement 
surgery for 42 Australian RA patients (31 patients undergo-
ing total knee arthroplasty (TKA) and 11 patients undergoing 
total hip arthroplasty (THA)), the subjects were followed for 
12 months postoperatively. The results were similar to ours, 
with statistically significant improvements in PF and BP for 
both knee and hip patients, while neither group improved 
regarding GH. Hip patients also showed better results in sub-
scales related to other aspects of psychology (VT and MH). 
Similar results have been found for osteoarthritis patients 
(Bachmeier et al. 2001) and in RA drug trials (Mease et al. 
2008, Wells et al. 2008), where aspects of patient psychology 
were less affected by pharmacological treatment. It has been 
proposed that the effect of successful RA treatment may first 
affect relief of pain, mobility, physical function, and physical 
role activities—and emotional well-being only later (Kosin-
ski et al. 2002). In a follow-up study of osteoarthritis patients 
undergoing THA (n = 108) and TKA (n = 86) (Bachmeier et 
al. 2001), the SF-36 at 12 months was less responsive than 
the WOMAC, which is a disease-specific questionnaire for 
patients with osteoarthritis of the lower limb (Bellamy et al. 
1988). The relative improvement was most pronounced for 
physical functioning and physical role functioning. Similarly 
to our data, the GH subscale after TKA remained unaltered.
According to the authors this might be explained by the fact 
that—even after a successful operation—pain and restrictions 
in daily life remain, making patients rate their general health 
as insufficient. Moreover, the chronic course of RA can make 
evaluation of a specific surgical procedure and its effect on the 
patient more challenging to interpret (Nelissen 2003), which 
should be kept in mind when comparing RA surgery and sur-
gery for osteoarthritis. In joint replacement studies including 
both osteoarthritis patients and RA patients (Espehaug et al. 
1998, Bullens et al. 2001), RA patients were more satisfied 
than osteoarthritis patients after surgery. It was suggested that 
the moderate correlation between satisfaction and postopera-
tive function could be partly explained by the different expec-
tations of the patients preoperatively (Bullens et al. 2001). 
As for osteoarthritis patients undergoing knee arthroplasty, 
outcome of pain and function is best after 12 months (Nils-
dotter et al. 2009) but major improvement is evident as early 
as 6 months postoperatively for RA patients. Improvement in 
pain has high priority in RA patients (Heiberg et al. 2005) and 
pain remains the most important indication for RA surgery. In 
our analysis, for every patient group there was a statistically 
significant improvement in the SF-36 subscale BP postopera-
tively compared to preoperatively. 
One important limitation of our analysis was the large loss to 
follow-up. This was a retrospective study based on question-
naire data from a register. The majority of patients only had 
one hospital admission. Follow-up questionnaires were sent 
by mail at 6 and 12 months without reminders. No statistically 
significant differences were found in age, preoperative SF-36 
scores, or HAQ score between responders and non-responders. 
The results were sensitive for imputation of baseline data at 12 
months for non-responders. Since data were collected from a 
register, we could not influence the number of follow-up occa-
sions. Repeated evaluations would have been interesting, as 
the greatest improvement was seen in the first 6 months. We 
lacked baseline data for a large number of patients, especially 
early in the inclusion period. One explanation could be an 
absence of routines for supplying the patients with question-
naires from the start. Hopefully RAKIR will provide opportu-
nities for further follow-up studies in the future. 
In conclusion, our data suggest that orthopedic RA-related 
surgery of the lower extremities has a strong effect on pain and 
physical function. Improvement is seen as early as 6 months 
postoperatively and is still apparent after 12 months.
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